Literature DB >> 8743990

Genomic organization of TEL: the human ETS-variant gene 6.

M Baens1, P Peeters, C Guo, J Aerssens, P Marynen.   

Abstract

We have constructed a detailed map of the genomic region containing the ETS-variant gene 6 (ETV6), involved in translocations and deletions associated with hematologic malignancies. Thirty-eight cosmids were characterized belonging to two contigs spanning 340 kb, and an EcoRl restriction map was developed. The gap between the two contigs, 2 kb in size, was closed by PCR. The contigs contain the complete coding sequence and the 5' and 3' UTRs of ETV6. Eight exons accounting for the ETV6 cDNA sequence were identified. The helix-loop-helix (HLH) motif is coded by exons 3 and 4, whereas exons 6-8 code for the ETS DNA-binding domain. All introns show consensus 5' donor and 3' acceptor splice sites. Introns 1 and 2 span 100 and 82 kb, respectively, and introns 3-7 range from 15 to 1.3 kb. An alternative exon 1 (exon 1B) is localized in intron 2. The 5' end of the ETV6 gene is associated with a CpG island characterized by the presence of four Notl, four Sacll, and three BssHll recognition sites and several SP1- and AP2-binding motifs. Alternative polyadenylation at the 3' end of the ETV6 gene generates the three transcripts of 6200, 4300, and 2400 nucleotides, respectively. The ETV6 gene spans 240 kb and is flanked at its 5' and 3' end by D12S1697 and D12S98, respectively. The markers D12S1095 and D12S89 are located in the first intron. Two new DNA polymorphisms were identified in the ETV6 gene, which will be useful for the analysis of loss of heterozygosity reported for the ETV6 gene in leukemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743990     DOI: 10.1101/gr.6.5.404

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  6 in total

1.  Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia.

Authors:  A M Ford; C A Bennett; C M Price; M C Bruin; E R Van Wering; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia.

Authors:  Johanna M Kralik; Wolfgang Kranewitter; Hans Boesmueller; Renate Marschon; Gertraud Tschurtschenthaler; Holger Rumpold; Kurt Wiesinger; Martin Erdel; Andreas L Petzer; Gerald Webersinke
Journal:  Diagn Pathol       Date:  2011-03-15       Impact factor: 2.644

3.  DisPredict: A Predictor of Disordered Protein Using Optimized RBF Kernel.

Authors:  Sumaiya Iqbal; Md Tamjidul Hoque
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 4.  Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators.

Authors:  Vladimir N Uversky
Journal:  Front Mol Biosci       Date:  2014-07-25

5.  Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia.

Authors:  M Eguchi-Ishimae; M Eguchi; K Tanaka; K Hamamoto; M Ohki; K Ueda; N Kamada
Journal:  Jpn J Cancer Res       Date:  1998-07

6.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.